CIP
EOLS icon

Chartwell Investment Partners’s Evolus EOLS Stock Holding History

Chartwell Investment Partners’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$664K Buy
40,978
+335
+0.8% +$4.68K 0.02% 383
2024
Q2 		$441K Buy
40,643
+16,550
+69% +$204K 0.02% 399
2024
Q1 		$337K Buy
+24,093
New +$313K 0.01% 404
2019
Q3 		– Sell
-74,085
Closed -$1.08M – 408
2019
Q2 		$1.08M Buy
+74,085
New +$1.47M 0.04% 375
2019
Q1 		– Sell
-75,882
Closed -$903K – 443
2018
Q4 		$903K Buy
+75,882
New +$1.08M 0.03% 404

Other funds holding EOLS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Chartwell Investment Partners's EOLS Position: Q3 2024 in Review

Chartwell Investment Partners increased its Evolus (EOLS) stake by 0.82% in Q3 2024, buying an estimated $4.68K and bringing the position to 40,978 shares worth $664K. The position accounts for 0.02% of the portfolio, ranked #383.

Chartwell Investment Partners first reported a position in EOLS in Q4 2018 and has held it in 5 quarters since. The position peaked at $1.08M in Q2 2019. 165 funds tracked by Wall St. Rank hold EOLS as of Q3 2024.

  • Chartwell Investment Partners held 40,978 shares of Evolus worth $664K as of Q3 2024.
  • Chartwell Investment Partners bought 335 Evolus shares in Q3 2024, an estimated $4.68K.
  • Evolus made up 0.02% of Chartwell Investment Partners's portfolio in Q3 2024, its #383 holding.
  • Chartwell Investment Partners first reported a position in Evolus in Q4 2018 and has held it in 5 quarters since.
  • Chartwell Investment Partners's Evolus position peaked at $1.08M in Q2 2019.
  • 165 funds tracked by Wall St. Rank held Evolus as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.